CoChat

Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy

Open access
Sutcigil, Levent, Oktenli, Cagatay, Musabak, Ugur, Bozkurt, Ali, Cansever, Adnan, Uzun, Ozcan, Sanisoglu, S. Yavuz, Yesilova, Zeki, Ozmenler, Nahit, Ozsahin, Aytekin, Sengul, Ali · 2007 · Clinical and Developmental Immunology

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-α, TGF-β1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF-α) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF-β1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF-β1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2007/76396

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Hamilton depression rating scale (HDRS) levels before (BT) and after (AT) sertraline treatment.
Figure 1 Hamilton depression rating scale (HDRS) levels before (BT) and after (AT) sertraline treatment.CC BY · PubMed Central
Figure 2 Interleukin-4 (IL-4) levels before (BT) and after (AT) sertraline treatment.
Figure 2 Interleukin-4 (IL-4) levels before (BT) and after (AT) sertraline treatment.CC BY · PubMed Central
Figure 3 Interleukin-12 (IL-12) levels before (BT) and after (AT) sertraline treatment.
Figure 3 Interleukin-12 (IL-12) levels before (BT) and after (AT) sertraline treatment.CC BY · PubMed Central
Figure 4 Transforming growth factor β1 (TGF- β1) levels before (BT) and after (AT) sertraline treatment.
Figure 4 Transforming growth factor β1 (TGF- β1) levels before (BT) and after (AT) sertraline treatment.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

Items 201–300 of 323

Metadata

Authors
Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., & Sengul, A.
Affiliations
Gülhane Askerî Tıp Akademisi (TR)
Venue
Clinical and Developmental Immunology
Published
2007
Volume
2007
Pages
1-6
ISSN
  • 1740-2522 (ISSN-L)
  • 1740-2530
OpenAlex
W1998520631
Cited by
315
References
36
Citations by year
2026: 2 · 2025: 15 · 2024: 19 · 2023: 13 · 2022: 9 · 2021: 26 · 2020: 24 · 2019: 16 · 2018: 14 · 2017: 21 · 2016: 28 · 2015: 11 · 2014: 28 · 2013: 17 · 2012: 16
FWCI
4.09
Type
journal article
Language
en
Open access
Locations
  • Clinical and Developmental Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • AYBU AVESIS (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Gülhane Military Medical Academy
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
major depressive disorder, sertraline, cytokines, chemokines, inflammatory cytokines, anti-inflammatory cytokines, IL-12, IL-4, TNF-α, TGF-β1, MCP-1, immunomodulation, antidepressant effects, Th1/Th2 balance
MeSH terms
Adult, Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Enzyme-Linked Immunosorbent Assay, Female, Humans, Interleukin-2, Male, Tumor Necrosis Factor-alpha, Interleukin-4, Cytokines, Interleukin-12, Chemokine CCL2, Sertraline, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.